The 2017 appropriation act highlights the various Expenditures for the ministry of water resources

This scheme is a Public-Private Partnership intervention that enables the Federal Government of Nigeria to leverage private sector funding for the construction or refurbishment of eligible road infrastructure projects in Nigeria. It focuses on the development of eligible road infrastructure projects efficiently and effectively that creates value for money through private sector discipline and also guarantees participants in the scheme timely and full recovery of funds provided for the construction or refurbishment of eligible road infrastructure projects in the manner prescribed in this executive order.

The Nigerian Nuclear Regulatory Authority (NNRA), established by the Nuclear Safety and Radiation Protection Act 19 of 1995 (the Act) is charged with the sole responsibility for nuclear safety and radiological protection regulation in Nigeria (Article 4 of the Act.) In this regard, the NNRA is empowered to license practices involving handling, transportation and storage of radioactive sources. This document provides the requirement for accreditation for land transportation of radioactive sources.

The National Youth Policy recognises the broader policy context in which it has been formulated and shall operate. It is guided largely by other national policy initiatives and it is also reflective of international programmes and conventions. This policy is based on a commitment to extensive consultations, respect for diversity of interests and opinion, input and consensus from the grassroots and local communities in the spirit of national ownership. It affirms and upholds the fundamental human rights of all youth, including their rights to fundamental freedoms, development opportunities and full participation in the democratic and governance processes, as well as in community and civic decision-making and development agenda.

This is an Act to restrict the use of foreign vessels in domestic coastal trade to promote the development of indigenous tonnage and to establish a cabotage vessel financing fund and for related matters.

This guideline document seeks to facilitate the establishment and development of national capacities to implement, manage, monitor, establish adequate information systems, develop expert human resources in cabotage administration and enforcement and generally promote the efficient operation of the cabotage regime. These objectives would be achieved by the development of guidelines, standards, codes of practice, and monitoring capabilities for the operators, enforcement agencies, and financial institutions, establishment of a comprehensive and up-to-date database, infrastructure for information exchanges upon which cabotage administration and enforcement can be processed, promotion of regular review of administrative and policy measures on cabotage and enforcement can be processed and establishment and strengthening of national and institutional cabotage implementation mechanisms.

This document highlights the guidelines on the registration for a national carrier, shipping companies/agents and cabotage operators

This document guides application for a license to possess and use an X-ray unit, equipment specifications for enclosed exposure facilities and training requirements.

Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of humans. It provides unified standards for the conduct of clinical data in Nigeria. The guidelines describe the responsibilities and expectations of all participants in the conduct of clinical trials, including investigators, monitors, sponsors and ethics committees.

These cosmetic Good Manufacturing Practice (GMP) guidelines are for the manufacture, storage and shipment of cosmetic products. The primary objective of the guidelines is to ensure that products are consistently manufactured in conformance with quality standards. It is concerned with all aspects of production and quality control.

Good manufacturing practice (GMP) is that part of quality assurance that ensures that pharmaceutical products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by their marketing authorizations. These guidelines apply to pharmaceutical, biological, and veterinary products and they are intended to help all stakeholders comply with the provisions of the National Agency for Food and Drug Administration and Control (NAFDAC) good manufacturing Practice Regulations for pharmaceutical products.

Cold chain management is a specialized area of Biopharmaceutical products management that begins when a Biopharmaceutical product is manufactured, stored and moves through the distribution chain until it gets to the end-user at the time of administration. It is required that the product be held and distributed in a controlled environment. It is necessary to have adequate control of all steps and procedures involved both in manufacturing and quality control, storage and distribution, to ensure that product quality is maintained. Therefore, this document was designed to guide importers and owners of storage facilities for medicines that require cold chain management. This is to provide stakeholders with the relevant regulatory requirements needed to maintain the compliance status of their operational activities.

The 2017 appropriation act highlighting the various Expenditures for the ministry of transport

These guidelines apply to all entities that have the authorization to put medicinal products into the Nigerian market. These guidelines are intended to help all stakeholders comply with the provisions of the GVP regulations. They provide detailed guidance for marketing authorization holders on establishing and maintaining a pharmacovigilance system including its quality management, pharmacovigilance system master file, adverse reaction reporting, risk management, post-authorization safety studies, risk communication and pharmacovigilance audit.

These guidelines apply to marketing authorization (MA) Holders intending to make changes to the quality section of the dossier as well as to the safety, efficacy and product labelling information for an antigen, intermediate or a finished vaccine product. This guidance should be read in conjunction with the NAFDAC guidelines on variations to a registered pharmaceutical product. It provides guidance for MA holders on the regulation of changes to the original MA dossier or product license for an approved vaccine in terms of procedures and criteria for the appropriate categorization and reporting of changes, and the data required to enable NAFDAC to evaluate the impact of the change on the quality, safety and efficacy of the vaccine.

This document outlines procedures for effective enrolment and implementation of the mobile authentication service MAS scheme. It provides guidelines for holders of a certificate of registration (HCR) – the applicant seeking to deploy MAS on their registered products, existing MAS providers deploying MAS technology; and MAS providers seeking entry as a NAFDAC approved service provider, and person(s) or group(s) requesting information, education and communication (IEC) materials on the MAS Scheme.

These regulations apply to all foods containing fats and oils that are manufactured, imported, exported, advertised, sold, distributed or used in Nigeria. It guides vitamin A fortification, source, additives, impurities and labelling of fats and oils

These regulations are practice-elaboration of the Nigeria basic ionizing radiation regulation, which is derived from the international basic safety standards for protection against ionizing radiation sources. They provide for the protection of patients, workers and the public from the harmful effects of exposure to ionizing radiation.

These regulations are practice-elaboration of the Nigeria basic ionizing radiation regulation, which is derived from the international basic safety standards for protection against ionizing radiation sources. They provide for the protection of patients, workers and the public from the harmful effects of exposure to ionizing radiation.

This document provides a checklist for the commissioning and regular inspection of nuclear medicine facilities.